France
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 742.99 M
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
2 |
USD 191.33 M
|
Dec. 31, 2023 | USD 28.77 | 0.25% |
|
France |
|
3 |
USD 165.07 M
|
Dec. 31, 2023 | USD 28.61 | 0.98% |
|
France |
|
4 |
USD 69.06 M
|
Dec. 31, 2023 | USD 7.91 | 1.05% |
|
France |
|
5 |
USD 29.73 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
6 |
USD 21.29 M
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
7 |
USD 18.72 M
|
Dec. 31, 2023 | USD 2.44 | 6.09% |
|
France |
|
8 |
USD 11.75 M
|
Dec. 31, 2023 | USD 1.18 | 2.98% |
|
France |
|
9 |
USD 10.48 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
10 |
USD 9.39 M
|
Dec. 31, 2023 | USD 4.49 | 2.38% |
|
France |
|
11 |
USD 7.26 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
12 |
USD 6.59 M
|
Dec. 31, 2023 | USD 7.60 | -5.89% |
|
France |
|
13 |
USD 2.45 M
|
Dec. 31, 2023 | USD 3.60 | 1.72% |
|
France |
|
14 |
USD 194.96 K
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
15 |
USD 136.82 K
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
16 |
USD 3.54 K
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
The Medical Instruments company in France with the highest Receivables is Ramsay Générale de Santé SA (Paris Stock Exchange: GDS.PA) at USD 742.99 M.
The Medical Instruments company in France with the lowest Receivables is Affluent Medical SA (Paris Stock Exchange: AFME.PA) at USD 0.00.
The top 10 Medical Instruments companies in France by Receivables are Ramsay Générale de Santé SA, Lisi S.A., Guerbet SA, Lumibird SA, Eurobio Scientific SA, Amplitude Surgical SA, EDAP TMS S.A., Biosynex SA, Nanobiotix S.A. and Euromedis Groupe.
The bottom 10 Medical Instruments companies in France by Receivables are Affluent Medical SA, bioMérieux S.A., Ikonisys S.A., Novacyt S.A., Predilife S.A., MEMSCAP, S.A., i2S SA, Median Technologies SA, Euromedis Groupe and Nanobiotix S.A..